ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk.

Ruth M de Tute et al.PubMed ↗Publisher ↗

No numbers read from the abstract.